BioStem Technologies, Inc. (BSEM) Misses Q1 EPS by 41c, provides guidance

BioStem Technologies, Inc. (OTC: BSEM) reported Q1 EPS of ($0.39), $0.41 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $10.1 million versus the consensus estimate of $55.2 million.

GUIDANCE:

BioStem Technologies, Inc. sees Q1 2026 revenue of $5-6 million.

For earnings history and earnings-related data on BioStem Technologies, Inc. (BSEM) click here.

You May Also Be Interested In

• Sandisk targets mid-to-high teens revenue growth through FY2030
• Jefferies sees a buying opportunity in this S&P 500 sector
• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating